Remdesivir
- PMID: 37061276
- PMCID: PMC9910426
- DOI: 10.1016/bs.podrm.2022.11.003
Remdesivir
Abstract
Remdesivir, marketed under the brand name Veklury, is an antiviral drug with a broad spectrum of activity. There were various countries where the use of Remdesivir for the treatment of COVID-19 was authorized during the pandemic. Remdesivir was first designed to treat hepatitis C, but it was later tested for Ebola virus sickness and Marburg virus infections. Remdesivir is a prodrug designed to facilitate the intracellular transport of GS-441524 monophosphate and its subsequent biotransformation into GS-441524 triphosphate, a ribonucleotide analogue inhibitor of viral RNA polymerase. The objective of this chapter is to provide a comprehensive review of Remdesivir (GS-5734), including its nomenclature, physiochemical properties, preparation methods, identification procedures, numerous qualitative and quantitative analytical techniques, ADME profiles, and pharmacological effects. In addition, the chapter provides a variety of chromatographic and spectroscopic techniques for separating brimonidine from other drugs in combination formulations.
Keywords: (GS-5734); Antiviral drug; COVID-19; Clinical pharmacology; GS-441524 monophosphate; HPLC, methods of preparation; Remdesivir; Spectrometric analysis.
Copyright © 2023 Elsevier Inc. All rights reserved.
Figures












Similar articles
-
Broad-Spectrum In Vitro Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524).Microbiol Spectr. 2021 Dec 22;9(3):e0153721. doi: 10.1128/Spectrum.01537-21. Epub 2021 Nov 24. Microbiol Spectr. 2021. PMID: 34817209 Free PMC article.
-
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease.J Antimicrob Chemother. 2020 Jul 1;75(7):1772-1777. doi: 10.1093/jac/dkaa152. J Antimicrob Chemother. 2020. PMID: 32361744 Free PMC article.
-
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.Eur J Med Chem. 2020 Sep 1;201:112527. doi: 10.1016/j.ejmech.2020.112527. Epub 2020 Jun 6. Eur J Med Chem. 2020. PMID: 32563812 Free PMC article. Review.
-
A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19.Drug Des Devel Ther. 2020 Aug 6;14:3215-3222. doi: 10.2147/DDDT.S261154. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32821086 Free PMC article. Review.
-
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor.Clin Pharmacokinet. 2021 May;60(5):569-583. doi: 10.1007/s40262-021-00984-5. Epub 2021 Mar 30. Clin Pharmacokinet. 2021. PMID: 33782830 Free PMC article. Review.
Cited by
-
Treatment of Ebola Virus Disease: From Serotherapy to the Use of Monoclonal Antibodies.Antibodies (Basel). 2025 Mar 5;14(1):22. doi: 10.3390/antib14010022. Antibodies (Basel). 2025. PMID: 40136471 Free PMC article. Review.
-
Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: network meta-analysis and budget impact analysis.Front Pharmacol. 2025 Apr 16;16:1537018. doi: 10.3389/fphar.2025.1537018. eCollection 2025. Front Pharmacol. 2025. PMID: 40308760 Free PMC article.
-
Navigating the Complex Landscape of Ebola Infection Treatment: A Review of Emerging Pharmacological Approaches.Infect Dis Ther. 2024 Jan;13(1):21-55. doi: 10.1007/s40121-023-00913-y. Epub 2024 Jan 19. Infect Dis Ther. 2024. PMID: 38240994 Free PMC article. Review.
-
Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis.Sci Rep. 2024 Apr 23;14(1):9303. doi: 10.1038/s41598-024-59957-w. Sci Rep. 2024. PMID: 38654033 Free PMC article.
-
Unlocking the potential of remdesivir: innovative approaches to drug delivery.Drug Deliv Transl Res. 2025 Apr 17. doi: 10.1007/s13346-025-01843-7. Online ahead of print. Drug Deliv Transl Res. 2025. PMID: 40244526 Review.
References
-
- Pashaei Y. Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic. Drug Discov. Ther. 2021;14(6):273–281. - PubMed
-
- Remdesivir (Compound) 2022. https://pubchem.ncbi.nlm.nih.gov/compound/121304016#section=3D-Conformer [cited 2022 24 March]; from.
-
- Remdesivir (HMDB0304869) The Metabolomics Innovation Centre (TMIC) 2022. https://hmdb.ca/metabolites/HMDB0304869 [cited 2022 24 March]; from.
-
- Remdesivir The Merck Index Online 2022. 2022. https://www.rsc.org/Merck-Index/monograph/m12252/remdesivir?q=unauthorize [cited 2022 24 March]; from.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical